Figure 1 | Scientific Reports

Figure 1

From: PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer

Figure 1

Differential expression of PFKP in normal tissue, cancer cell lines, and tumor samples was analyzed in GTX, CCLE, and TCGA. (A) The content of PFKP in normal human tissues is displayed in a box diagram. (B) Distinctive expression of PFKP between tumor and nontumor samples was analyzed in TCGA by a box diagram across cancers. (C) Expression of PFKP was compared in paired cancer samples across cancers in TCGA. (D) Distinction expression of PFKP between tumor and nontumor samples were analyzed in GEO by box diagram across pan-cancer. (E) Expression of PFKP in different tumor stages and across cancers is displayed in a box diagram. FPKM, fragments per kilobase million. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. ns, not statistically significant.

Back to article page